Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982293 · ClinicalTrials.gov registry record · Phase 2
The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes
A Phase 2 study, sponsored by pico-tesla Magnetic Therapies.
- Terminated
- Registry status
- Phase 2
- Development phase
- 165
- Enrollment target
NCT00982293 is a Phase 2 study that was terminated before completion, run by pico-tesla Magnetic Therapies. The registered enrollment target is 165 participants.
The verdict
NCT00982293, a Phase 2 study, was terminated before completion, sponsored by pico-tesla Magnetic Therapies.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to see if using a device called the Resonator, that puts out very low level electromagnetic fields, effects blood glucose and A1c levels in people with Type 2 Diabetes.
Interventions
- DEVICE Resonator device
- DEVICE Resonator device - sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982293
The ClinicalTrials.gov registry entry for NCT00982293 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is pico-tesla Magnetic Therapies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Resonator device is the first listed.
NCT00982293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982293 about?
NCT00982293 is a clinical study titled "The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes". The purpose of this study is to see if using a device called the Resonator, that puts out very low level electromagnetic fields, effects blood glucose and A1c levels in people with Type 2 Diabetes.
What is the current status of trial NCT00982293?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 165 participants. The study started on 2009-09. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00982293?
The interventions under investigation include: Resonator device (DEVICE), Resonator device - sham (DEVICE).
Who is sponsoring clinical trial NCT00982293?
This trial is sponsored by pico-tesla Magnetic Therapies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.